United Therapeutics (NASDAQ:UTHR) Downgraded by StockNews.com to Buy

StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Tuesday morning. Other equities analysts have also issued research reports about the company. SVB Leerink started coverage on United Therapeutics in a research note on Monday, February 5th. They set an outperform […]

Related Keywords

United States ,Canada ,Martinea Rothblatt ,Paula Mahon , ,Securities Exchange Commission ,Nasdaq ,Prudential Plc ,Great West Life Assurance Co ,Covestor Ltd ,Wells Fargo Company ,United Therapeutics Company Profile ,United Therapeutics Corporation ,Goldman Sachs Group ,United Therapeutics ,Free Report ,Wells Fargo ,Moderate Buy ,Get Free Report ,Exchange Commission ,West Life Assurance ,Pension Plan Investment Board ,Therapeutics Corporation ,United Therapeutics Daily ,Nasdaq Uthr ,Suthr ,Medical ,91307c10 ,Downgrade ,Stocknews Com ,